⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Sera Prognostics executive sells over $85k in stock

Published 2024-05-15, 06:28 p/m
SERA
-

In a recent financial move, Paul Kearney, the Chief Data Officer of Sera Prognostics, Inc. (NASDAQ:SERA), has sold a portion of his holdings in the company. The transaction, which took place on May 15, 2024, involved the sale of 10,387 shares of Class A Common Stock at an average weighted price of $8.24 per share, resulting in a total value of approximately $85,588.

The shares were sold in a range of prices from $8.12 to $8.38. This sale was carried out to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). It's important to note that this sale was not a discretionary decision by Kearney but was mandated by the company's policy requiring tax obligations to be satisfied through such "sell to cover" transactions.

Following this sale, Kearney's remaining stake in Sera Prognostics stands at 185,300 shares of Class A Common Stock. The company, which specializes in medical laboratory services, has not made any additional comments regarding this transaction.

Investors and security holders of Sera Prognostics can request detailed information about the specific prices at which the block trade was executed from Kearney, should they wish to gain a deeper understanding of the transaction.

InvestingPro Insights

Amidst the news of Paul Kearney's recent stock sale, Sera Prognostics, Inc. has been navigating through a challenging financial landscape. According to real-time data from InvestingPro, the company's market capitalization stands at a modest $275.16 million. The company's performance metrics reveal a Price-to-Earnings (P/E) ratio of -7.77, reflecting the market's anticipation of future earnings growth despite current unprofitability.

InvestingPro Data further indicates that Sera Prognostics has experienced a significant revenue decline of -37.58% over the last twelve months as of Q1 2024. This financial performance is coupled with a concerning operating income margin of -18247.09%, suggesting that the company's expenses far exceed its revenue. In the face of these challenges, the stock has seen a remarkable six-month price total return of 401.79%, a figure that stands out in the company's recent financial history.

An InvestingPro Tip points out that Sera Prognostics holds more cash than debt on its balance sheet, which could provide some financial stability and flexibility. Additionally, the company's liquid assets exceed its short-term obligations, indicating a solid position to cover immediate liabilities. Investors considering the company's potential should note that Sera Prognostics does not pay a dividend, which may influence investment strategies focused on income generation.

For those looking to delve deeper into Sera Prognostics' financials and strategic outlook, InvestingPro offers more comprehensive analysis and tips. Currently, there are an additional 9 InvestingPro Tips available for Sera Prognostics, which can be found at https://www.investing.com/pro/SERA. Interested readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, providing even more insights to inform their investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.